nucleotide biosynthesis; salvage; oxypurine; nucleoside; ribose; heart; rat IN THE AEROBIC HEART a critical balance exists between production of ATP and its utilization.
If the heart becomes ischemic, this delicate balance is disturbed, and energy-rich phosphates are broken down to the nucleosides and purine bases adenosine, inosine, hypoxanthine, xanthine, and uric acid. These apolar compounds can pass the cellular membrane and enter the bloodstream (2, 9). Because of this loss of purines, ATP levels will remain below control levels after reoxygenation (see, e.g., Ref. 18) . To restore these adenine nucleotide pools three main pathways exist (Fig. 1 ). 1) In adenosine phosphorylation, adenosine is directly phosphorylated to AMP by adenosine kinase. The maximal incorporation rate in rat heart amounts to about 50 nmol. min-' l g dry wt-' (16) . This pathway is energetically economical. However, the adenosine concentration in blood is low, and this could be a restricting factor for adenosine phosphorylation. 2) In hypoxanthine salvage, hypoxanthine can be phosphorylated with &phosphoribosyl-1-pyrophosphate (PRPP) to form IMP (5, 12, 14, 22) . IMP is a crucial branching point between adenine and guanine nucleotide synthesis. In rat heart the hypoxanthine incorporation rate into ATP can amount to 3 nmol mine1 l g dry wt-l (14) . 3) In de novo synthesis, purine nucleotides (adenine and guanine nucleotides) are also synthesized from small precursor molecules (among others, glycine, C02). In a lo-step synthesis from PRPP, IMP is formed. De novo production rate of IMP in rat heart is about 0.1 nmol. min.
g dry wt-' (24) . This process is stimulated after anoxia, ischemia, and hypertrophy.
As an explanation for this phenomenon, an enhanced synthesis of PRPP by acceleration of the hexose-monophosphate shunt has been proposed (24) . To bypass this shunt, ribose (a precursor of PRPP) can also be supplied (25) .
We decided to study the incorporation of [V4C]hypoxanthine into normoxic or postischemic rat hearts in the presence of D-ribose to investigate whether hypoxanthine incorporation is also PRPP dependent. Because inosine, a precursor of hypoxanthine, is used as a cardioprotective and vasodilatory agent (4, 10, 11, 21, 23) , [8- 14C] inosine incorporation rates in aerobic and postischemic rat hearts were also determined. Mammalian cells lack inosine kinase (22) ; therefore inosine is converted to hypoxanthine and ribose-l-phosphate. Subsequently, part of the hypoxanthine is converted to IMP; ribose-lphosphate can serve as a precursor of PRPP.
Hypoxanthine and inosine are incorporated not only into adenine nucleotides but also into guanine nucleotides. To our knowledge no data about purine incorporation into myocardial guanine nucleotides have been published, although Swain et al. (20) The perfusion experiment was terminated by freeze clamping the heart between two aluminum blocks precooled in liquid N2 (-190°C). After being weighed, the heart was ground in a mortar, and about 0.5 g was mixed with 3.0 ml 0.8 N HClO, at -190°C. The other half was freeze dried to determine dry weight. The acid homogenate was thawed and~centrifuged at 4°C. Two milliliters of the supernatant fluid were neutralized with about 200 ~16 N KOH. After centrifugation, 20 ~1 of the supernatant fluid were used for the determination of nucleotides and creatine phosphate with HPLC according to Harmsen et al. (8) .
To determine 14C radioactivity in the ATP and GTP fractions, a fast, .isocratic HPLC separation was developed. A Partisil-IO-SAX column (Whatman, Maidstone, UK) was eluted at 3.0 ml/min with 0.42 M KHzP04, pH 4.20. One milliliter of neutralized heart extract was injected. Fractions were collected and counted (Fig. 2) . In addition 50 ~1 of this extract were counted to determine total 14C-radioactivity uptake in the heart. Values were corrected for blanks. 14C-counting efficiency was 85-90%.
Coronary flow measurements. Mean coronary flow was measured by timed collection of perfusate in the periods described above.
Statistical analysis. For statistical evaluation, analysis of variance was used (2.way classification); further comparisons were made using Scheffe's method for multiple comparisons (19) . When only two means were compared, Student's unpaired t test was used. P > 0.05 was considered not significant (NS). Results are given as means t SE. Three treatments (hypoxanthine, inosine, or hypoxanthine + ribose) were tested during two conditions (normoxia or reperfusion). Analysis of variance revealed that one experiment (hypoxanthine + ribose during normoxia), in which the ATP and GTP biosynthesis rates were 4.43 and 0.83 nmol. min-' . g dry wt-', respectively, contributed the major part of variance. The means t SD for all experiments (n = 26) were 1.06 t 0.71 and 0.31 t 0.11 nmol . mine1 l g dry wt-', respectively. According to the rejection rule of Anscombe and Tukey (see Ref. 19) with a premium of 5%, the values of the experiment mentioned earlier were considered as gross errors and rejected. The recalculated biosynthesis rates for ATP and GTP for all experiments were 0.92 t 0.19 and 0.29 t 0.06 nmol l min-' . g dry wt-', respectively (n = 25).
RESULTS
In Fig. 3 mean coronary flows during the various periods are presented. During period 2, flow was restricted to 13 ml. min-' l g dry wt-' (flow reduction of SO%, P < 0.001 vs. control). In the first 5 min of reperfusion the average flow increased to above control level (Level 3, reactive hyperemia; P < 0.001 vs. control), but in period 4 flows in control and postischemic hearts were comparable. In preliminary experiments we investigated the time dependency of hypoxanthine and inosine release during and after myocardial ischemia (Fig. 4) . After induction of ischemia, inosine and hypoxanthine appeared in the coronary effluent. However, within the first 5 min of reperfusion (reactive hyperemia, period 3) inosine and hypoxanthine returned to control levels (CO.1 PM).
Total normoxic purine release (i.e., adenosine, inosine, hypoxanthine, xanthine, and uric acid) was about 20
nmol . min-' . g dry wt-' ( Fig. 5 ; period 2, control). This purine release was increased about six times during ischemia (P < 0.001 vs. control) and nine times during reactive hyperemia (P < 0.001 vs. control). During normoxie perfusion 64% of the purines released consisted of uric acid, but during ischemia this percentage fell to 28%. The percentages of the other purine compounds in the perfusate collected during normoxia were (with ischemic values in parentheses) adenosine 5 (ll), inosine 17 (38), hypoxanthine 8 (13) , and xanthine 5 (9), respectively. 5 . Total purine release (adenosine + inosine + hypoxanthine + xanthine + uric acid) from isolated rat hearts. Periods l-3 are defined in legend of Fig. 3 . Values are means t SE (n = 4-6). A, P < 0.001 vs. control (t statistics).
In Table 1 , the biosynthesis of ATP and GTP from 0.02 mM hypoxanthine or inosine is presented. Analysis of variance for hypoxanthine and inosine incorporation rates in the ATP fraction showed no significant interaction (P = 0.65) *between the conditions normoxia and reperfusionon the one hand and the three treatments (infusion of hypoxanthine, of hypoxanthine + ribose, and of inosine) on the other hand. Thus the pattern for the three treatments was similar for normoxia compared with reperfusion. Incorporation rates during reperfusion were significantly (P c 0.0001) increased compared with the normoxic controls. Comparison of the three treatments proved them to be statistically different (P < 0.0001). In addition, by Scheffe's method of multiple comparison the incorporation rates in the group treated with hypoxanthine + ribose were found to be different from the groups treated with hypoxanthine or inosine, the latter two not being different. Also the GTP incorporation rates showed no significant interaction (P = 0.97) between normoxia/reperfusion and the three treatments. The significant differences paralleled those of the ATP incorporation rates. Besides incorporation into nucleotides, the other met- abolic fate of inosine and hypoxanthine was conversion to xanthine and uric acid. We determined [8-'4C]inosine or hypoxanthine conversion in the coronary effluent (Table 2 ). About 80% of both purines passed the heart unchanged and lo-15% were metabolized during a single passage through the coronary vasculature. About 0.8% of hypoxanthine was taken up by the heart, whether or not ribose was added. On the other hand, [8-'4C]inosine uptake was about 1.5%, which is twice the hypoxanthine uptake (P < 0.001). Incorporation rates were comparable for hypoxanthine and inosine. During reperfusion, the uptake figures for these purines were comparable to the control values. In the statistical analysis of the uric acid data neither the interaction nor the reperfusion versus normoxic data were statistically significant (P = 0.76; P = 0.60, respectively). The three treatments, however, were significantly different (P c 0.0001); by Scheffe's method of multiple comparison a significant difference (P c 0.001) existed between the group treated with inosine and the groups perfused with hypoxanthine in the presence or absence of ribose. Furthermore, perfusion with a mixture of ribose and hypoxanthine increased the uric acid release significantly (P < 0.05) compared with hypoxanthine infusion. Table 3 shows the data on energy-rich phosphates determined in freeze-clamped hearts. During ischemia, total adenine nucleotides (TAN), ATP, and creatine phosphate (CrP) fell (20, 30 , and 50%, respectively). Two-way analysis of variance showed a borderline significant interaction between normoxic and reperfused hearts with respect to TAN (P = 0.13) and ATP (P = 0.06), i.e., the decrease of TAN and ATP due to ischemia and reperfusion disappeared when 0.02 mM inosine was added to the reperfusion buffer. CrP during reperfusion showed an overshoot in all groups studied (P < 0.001, interaction 0.71).
H41 DISCUSSION

Theoretically
nucleotide synthesis rates from radiolabeled purines should be calculated on the basis of specific activity of the intracellular purine compounds. However, we were unable to measure intracellular hypoxanthine and inosine concentrations.
To overcome this problem, we assumed that the hypoxanthine and inosine concentrations in the heart cell were reflected by the concentrations in the coronary effluent. As is shown in Fig. 4 , 5 min after ischemia inosine and hypoxanthine concentrations returned to normal values (~0.1 PM). Therefore we concluded that within 5 min after ischemia, inosine and hypoxanthine concentrations in the heart cell had also returned to control values, which are low in heart (<l PM, see, e.g., Ref. 20) . To minimize isotopic dilution, 0.02 mM [8-'4C]hypoxanthine or -inosine were used. Hypoxanthine and inosine incorporation rates were about 0.4 nmol . min-l l g dry wt-' into the ATP and 0.1 into the GTP pool (8 and 2% of the 14C radioactivity accumulated in the heart, respectively; see Table 1 ). In earlier experiments we showed that about 75% of [U-"C]inosine (also labeled in the ribose ring) recovered in nucleotides was incorporated into the combined ATP and GTP pool both in normoxic and in reperfused hearts (7). Therefore we estimated that the total hypoxanthine and inosine incorporation into adenine and guanin'e nucleotides amounts to about 0.7 nmol min-' . g dry wt-' during aerobic perfusion. After ischemia a twofold increase in the incorporation rates of these purines into ATP and GTP is seen. The total amount of radioactivity taken up by the heart is not changed, however. Thus the percentage of hypoxanthine and inosine in heart,'con- Values are means t SE (n = 3-6) in Pmwg dry wt. Hearts were perfused as described in legend to verted to ATP and GTP, is increased. The rest of the will be about 1.5. This is insufficient by far to account 14C label is found in the fraction containing the nucleofor the observed total restoration. There are two other sides and oxypurines (see Ref. 8) . We have not measured myoc ardial nucleosides a .nd oxypurines, but we assume that more than 80% of the myocardial purine fraction consists of hypoxanthine (during hypoxanthine infusion) or inosine (during inosine infusion), as reflected by the perfusate concen tration (see Table 2 ). If hypoxanthine and inosine were evenly distributed over the myocardial cells and extracellular space, intracellular hypoxanthine or inosine concentrations are estimated to be minimally 15 PM. These concentrations are in' the same order of magnitude as found in the perfusate. Therefore ATP and GTP biosynthesis is not limited by purine transport but is regulated intracellularly. According to Zimmer et al. (24) , the NADP-to-NADPH ratio decreases during and after ischem ia, and the hexose-monophosphate shunt is accelerated. As a result of this process, ribose -5phos-phate levels are increased, which in turn increases the PRPP concentration.
Because hypoxanthine phosphorylation is PRPP dependent, this could give a reasonable explanation for increased salvage rates after ischemia. It is possible to bypass the hexose-monophosphate shunt by supplying ribose as a precursor for PRPP (25) . Indeed after ribose infusion, a significant increase in salvage rates is seen, which is further enhanced after ischemia.
Na .mm (14) found that during normox ic perfusion 0.01 mM inosine or hypoxanthine is incorporated into isolated rat hearts at a rate of about 3 nmol l min-' l g dry Wt-l. Using myocardial homogenates of the same species, Maguire et al. (13) measured hypoxanthine phosphoribosyltransferase (HPRT) activities with a maximal initial velocity ( Vmax) of about 40 prnol. min-' . g dry wt-'. This is about 10,000 times higher than the salvage rates reported by Namm (14) or found in our experiments. Although an in vitro enzyme activity measurement can hardly be compared with in vivo activity, it seems that the hypoxanthine incorporation is not limited by the potentially available HPRT activity. Raivio et al. (15) have found a striking correlation between PRPP synthesis and cellular phosphate concentration in human fibroblasts. Myocardial PRPP synthesis could be regulated by phosphate concentration as well.
During hypoxanthine perfusion (with or without ribose) after ischemia, a slight (NS) increase of TAN is known pathways that could account for ATP biosynthesis, namely adenosine phosphorylation and de novo synthesis. Adenosine phosphorylation accounts maximally for 50 nmol. min-l l g dry wt-' (14, 16) . However, the adenosine concentration in the perfusate at the end of the ischemic period is about 1.2 pmol/l and is lowered within 5 min of reperfusion to 0.04 pmol/l. Therefore, under these experimental conditions, adenosine phosphorylation will be low because of lack of substrate. De novo synthesis in isolated rat hearts is 0.1 nmol . min-' l g dry wt-' (23) . This synthesis rate is PRPP dependent and is accelerated after ischemia. Whether de novo synthesis is stimulated by inosine is unknown at this moment, but it seems unrealistic to assume that the restoration of TAN and ATP is due to de novo synthesis.
Bates et al. (1) postulated the existence of a pool of nonacid-extractable ATP, which under certain conditions can be converted to acid-extractable ATP. It remains to be seen whether this explanation is applicable to our results.
During reperfusion an overshoot of creatine phosphate is seen (Table 3 ). In the model of Saks et al. (17) CrP serves as an "energy carrier" from mitochondria to sites of utilization.
In this scheme it is possible for the mitochondria to start producing energy after mild ischemia, without direct utilization.
For that reason, no CrP overshoot would be expected after severe ischemia, when the mitochondria are damaged (see Ref. 18 ).
To our knowledge, this is the first report describing purine incorporation into the myocardial GTP pool, although Swain et al. (20) recently reported restoration of GTP levels by de novo synthesis in dog heart. It is interesting to see that the purine incorporation rate into GTP is about 25% of that of ATP, although the GTP content in 'heart is only about 5% of the ATP content. This indicates a faster recovery of GTP after ischemia. Our final conclusions are that hypoxanthine and inosine are,incorporated in both the ATP and GTP pool in the heart. This process is stimulated after ischemia and by ribose perfusion and is thereby dependent on myocardial PRPP concentrations.
Inosine especially seems to restore ATP levels, and this could (partly) explain its beneficial action. seen. During postischemic inosine infusion, however, TAN and ATP are about 5 pmol/g dry wt higher. ATP
